Graft-versus-host disease (GVHD) is an immune-mediated reaction and a major complication following allogeneic hematopoietic stem cell transplantation (HSCT). It can affect between 40 …

Chronic GVHD of the skin can cause color changes (red, pink, purple, brown or white), thinning or thickening, hardening, rashes, scaly areas, bumps, sores or blisters (small pockets of fluid). …

Graft-versus-host disease (GVHD) is an immune-mediated multisystemic disorder and the leading cause of morbidity after allogeneic hematopoietic stem cell transplantation. Peripheral nervous …

Aug 11, 2006 · Chronic graft-versus-host disease (cGVHD) is a multisystem disease often presenting with prominent skin involvement. Traditionally, two types of cutaneous GVHD have …

Transfusion-associated graft-versus-host disease (TA-GVHD) is a rare but fatal complication of blood transfusion that usually develops two to 30 days following a blood transfusion giving rise …

Acute GVHD is considered ‘classic’ if onset occurs within 100 days of allogeneic stem cell transplantation, ‘persistent’ if it lasts beyond 100 days, ‘recurrent’ if it resolves but reappears …

Feb 11, 2025 · What is chronic GVHD? GVHD happens when new, transplanted stem and immune cells attack healthy cells in the recipient’s body. Chronic GVHD is a condition that …

Oct 31, 2024 · Chronic graft-versus-host disease (cGVHD) is a multifaceted condition that can impact various body systems, with the skin being a primary target. For patients and their …

Apr 30, 2022 · Summary: Graft-versus-Host-Disease (GVHD) occurs when transplanted donor cells attack the patient’s body. It can affect virtually every organ in the body and may require …

This article aims to provide a comprehensive overview on the variable cutaneous presentations of acute and chronic GvHD for a proper and early diagnosis on the one hand, and to discuss …